Mylan begins commercial operations in India with ARV product launch
Mylan Pharmaceuticals Private Limited has launched portfolio of 18 antiretroviral (ARV) products, including heat stable, combination, and pediatric formulations, for the treatment of HIV/AIDS in India.
Original Article: Mylan begins commercial operations in India with ARV product launch
NEXT ARTICLE